GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Neogen Corp (MEX:NEOG) » Definitions » Cyclically Adjusted PB Ratio

Neogen (MEX:NEOG) Cyclically Adjusted PB Ratio : 1.58 (As of Oct. 09, 2024)


View and export this data going back to 2022. Start your Free Trial

What is Neogen Cyclically Adjusted PB Ratio?

As of today (2024-10-09), Neogen's current share price is MXN377.71. Neogen's Cyclically Adjusted Book per Share for the quarter that ended in May. 2024 was MXN238.69. Neogen's Cyclically Adjusted PB Ratio for today is 1.58.

The historical rank and industry rank for Neogen's Cyclically Adjusted PB Ratio or its related term are showing as below:

MEX:NEOG' s Cyclically Adjusted PB Ratio Range Over the Past 10 Years
Min: 1.46   Med: 8.77   Max: 14.89
Current: 1.77

During the past years, Neogen's highest Cyclically Adjusted PB Ratio was 14.89. The lowest was 1.46. And the median was 8.77.

MEX:NEOG's Cyclically Adjusted PB Ratio is ranked better than
59.35% of 123 companies
in the Medical Diagnostics & Research industry
Industry Median: 2.12 vs MEX:NEOG: 1.77

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted book value per share of a company over the past 10 years.

Neogen's adjusted book value per share data for the three months ended in May. 2024 was MXN246.667. Add all the adjusted book value per share for the past 10 years together and divide the count will get our Cyclically Adjusted Book per Share, which is MXN238.69 for the trailing ten years ended in May. 2024.

Shiller PE for Stocks: The True Measure of Stock Valuation


Neogen Cyclically Adjusted PB Ratio Historical Data

The historical data trend for Neogen's Cyclically Adjusted PB Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Neogen Cyclically Adjusted PB Ratio Chart

Neogen Annual Data
Trend May15 May16 May17 May18 May19 May20 May21 May22 May23 May24
Cyclically Adjusted PB Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 8.70 9.56 4.56 2.50 1.58

Neogen Quarterly Data
Aug19 Nov19 Feb20 May20 Aug20 Nov20 Feb21 May21 Aug21 Nov21 Feb22 May22 Aug22 Nov22 Feb23 May23 Aug23 Nov23 Feb24 May24
Cyclically Adjusted PB Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 2.50 3.15 2.23 2.16 1.58

Competitive Comparison of Neogen's Cyclically Adjusted PB Ratio

For the Diagnostics & Research subindustry, Neogen's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Neogen's Cyclically Adjusted PB Ratio Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Neogen's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where Neogen's Cyclically Adjusted PB Ratio falls into.



Neogen Cyclically Adjusted PB Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PB Ratio takes the Book Value per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/B calculation. Because it considers this 10-year average, it's often referred to as the CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio.

Neogen's Cyclically Adjusted PB Ratio for today is calculated as

Cyclically Adjusted PB Ratio=Share Price/ Cyclically Adjusted Book per Share
=377.71/238.69
=1.58

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Neogen's Cyclically Adjusted Book per Share for the quarter that ended in May. 2024 is calculated as:

For example, Neogen's adjusted Book Value per Share data for the three months ended in May. 2024 was:

Adj_Book=Book Value per Share/CPI of May. 2024 (Change)*Current CPI (May. 2024)
=246.667/132.5091*132.5091
=246.667

Current CPI (May. 2024) = 132.5091.

Neogen Quarterly Data

Book Value per Share CPI Adj_Book
201408 42.324 100.352 55.886
201411 46.161 99.635 61.392
201502 50.933 99.032 68.151
201505 54.481 100.333 71.953
201508 61.438 100.548 80.967
201511 62.824 100.135 83.136
201602 70.035 100.040 92.766
201605 74.291 101.355 97.126
201608 78.202 101.617 101.976
201611 87.829 101.829 114.291
201702 88.827 102.779 114.522
201705 86.369 103.256 110.838
201708 84.968 103.587 108.691
201711 94.121 104.072 119.839
201802 98.919 105.052 124.773
201805 108.279 106.148 135.170
201808 107.462 106.383 133.853
201811 117.321 106.338 146.196
201902 114.568 106.649 142.348
201905 120.039 108.048 147.215
201908 126.382 108.245 154.712
201911 128.083 108.519 156.398
202002 132.725 109.139 161.146
202005 151.826 108.175 185.979
202008 155.011 109.662 187.306
202011 147.101 109.793 177.535
202102 157.993 110.968 188.662
202105 155.848 113.576 181.828
202108 159.737 115.421 183.386
202111 172.287 117.269 194.677
202202 165.684 119.703 183.410
202205 161.998 123.323 174.065
202208 164.617 124.958 174.565
202211 278.301 125.607 293.593
202302 265.184 126.928 276.845
202305 257.248 128.314 265.658
202308 245.529 129.538 251.161
202311 252.593 129.548 258.366
202402 247.763 130.930 250.751
202405 246.667 132.509 246.667

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Neogen  (MEX:NEOG) Cyclically Adjusted PB Ratio Explanation

Compared with the regular PB Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PB Ratio smoothed out the fluctuations of book value during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PB Ratio should give similar results to regular PB Ratio.


Neogen Cyclically Adjusted PB Ratio Related Terms

Thank you for viewing the detailed overview of Neogen's Cyclically Adjusted PB Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Neogen Business Description

Traded in Other Exchanges
Address
620 Lesher Place, Lansing, MI, USA, 48912
Neogen Corporation, headquartered in Lansing, Michigan, develops, manufactures, and markets various products for food and animal safety. In food safety, Neogen performs diagnostics to detect unintended substances in food and animal feed, such as pathogens, allergens, and drug residues, for food and feed processing companies. In animal safety, Neogen sells veterinary instruments, pharmaceuticals, disinfectants, and genomics tests for animals, including cattle, horses, and canines. Sales in the United States account for maximum revenue, and it also has its presence in United Kingdom and other countries.